Rotterdam-based sleep technology company Somnox has announced a strategic partnership with Zovio to expand its sleep solutions into hospitals, mental health institutions, and healthcare organizations, marking a shift from primarily direct-to-consumer sales.

Julian Martijn Jagtenberg, CEO of Somnox, emphasized that the collaboration will help make their sleep solutions more accessible and affordable for healthcare providers and patients.

Somnox develops a sleep companion device that uses patented technology to mimic calming breathing patterns, helping to reduce stress and anxiety and facilitate natural sleep onset.

This partnership leverages Zovio's extensive healthcare network and procurement platform, which offers over 18,000 products with transparent pricing and seamless integration into healthcare procurement systems.

Somnox aims to increase its impact on improving sleep quality globally by making its patented, science-backed sleep devices more accessible, affordable, sustainable, and effective for those in need.

Founded by Joep Jagtenberg, Somnox has a goal to help 100 million people worldwide achieve better sleep by 2030.

This strategic move addresses systemic procurement issues in healthcare, expanding the reach of sleep technology and integrating it into health and wellness infrastructure.

The partnership comes seven months after Somnox achieved profitability following years of financial losses, signaling a new phase of growth.

Zovio, based in Gelderland, specializes in streamlining healthcare procurement processes through a modern webshop that connects buyers directly with manufacturers, facilitating easier access to products like those from Somnox.

This collaboration aligns with broader industry trends of incorporating innovative sleep solutions into healthcare and wellness sectors, potentially leading to further market growth and new partnerships.